EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications. EMBO Press represents the policies and practices of the five EMBO scientific publications that serve the global life science community.
The five journals of EMBO Press publish important advances in the life sciences from around the globe, ranging from computational, synthetic and systems biology to molecular medicine. All papers selected for publication have passed a transparent and fair editorial peer-review process that ensures a reliable scientific literature. The EMBO peer review process relies on subject experts, academic advisors and dedicated editors. These focus on the evaluation of the quality and strength of the data presented and the veracity of the claims based on this data.
One of the goals of EMBO Press is to make it easier for scientists to discover, read, assess and re-use research:
Authors are encouraged to include source data alongside figures and article text in EMBO Press scientific publications
Researchers can customize the way they read papers at a level of detail that suits their needs
Restructuring the way papers are presented obviates the need for a separate, unedited supplementary information section
Synopses enhanced by visual summaries help to make articles more accessible to browsing by the general reader
Ever since the Asilomar Conference on ‘Recombinant DNA' in February 1975, regulatory policies relating to recombinant DNA technology have focused on the idea that this technology implies threats to human health and the environment [